Manufacturer record
Galpha Laboratories Limited: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
11 batches manufactured by Galpha Laboratories Limited (Himachal Pradesh) were declared Not of Standard Quality between August 2021 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: IFIS25026, Iron with Folic Acid Syrup IP (exp Apr 2027). CDTL, Indore (CDSCO lab) found it not of standard quality: The sample does not conform to I.P with respect to the tests for Assay of Ferrous Sulphate equivalent to Elemental Iron and Free ferric. Listed in the February 2026 alert.
Records by type
11 records linked to Galpha Laboratories Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Iron with Folic Acid Syrup IP | Batch IFIS25026Mfg Nov 2025 · Exp Apr 2027 | The sample does not conform to I.P with respect to the tests for Assay of Ferrous Sulphate equivalent to Elemental Iron and Free ferric compounds.Assay | CDTL, IndoreCDSCO lab | Feb 2026 |
| Bromhexine Hydrochloride Syrup-4mg/5ml | Batch BHS24002Mfg Mar 2024 · Exp Feb 2027 | ContentOther | Drugs Testing Laboratory, Madurai-19State lab | Jan 2026 |
| Iron and Folic Acid Syrup IP | Batch IFIS23015Mfg Aug 2023 · Exp Jan 2025 | Assay of Folic AcidAssay | RDTL GuwahatiCDSCO lab | Jun 2024 |
| Diclofenac Sodium and Paracetamol Tablets IP | Batch RCT230 50Mfg Jun 2023 · Exp Feb 2026 | The sample does not conforms to claim as per IP in respect to the Test of DescriptionDescription | CDL KolkataCDSCO lab | May 2024 |
| Paracetamol Tablets IP 500mg. (Galpara) | Batch GPT22003Mfg Jul 2022 · Exp Jun 2025 | DissolutionDissolution | RDTL GuwahatiState lab | Dec 2023 |
| Paracetamol Tablets I.P. 500 mg. (Galpara) | Batch GPT22001Mfg Jul 2022 · Exp Jun 2025 | DissolutionDissolution | RDTL GuwahatiState lab | Sep 2023 |
| PARACETAMOL TABLETS I.P. 500 mg., (Galpara) | Batch GPT22002Mfg Jul 2022 · Exp Jun 2025 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Sep 2023 |
| Paracetamol Tablets IP 500 mg (Galpara) | Batch GPT22002Mfg Jul 2022 · Exp Jun 2025 | DissolutionDissolution | RDTL GuwahatiState lab | May 2023 |
| Atorvastatin Tablets IP 20 mg | Batch AVAT21006Mfg May 2021 · Exp Apr 2023 | DissolutionDissolution | RDTL GuwahatiState lab | Sep 2022 |
| Atorvastatin Tablets IP 20 mg. | Batch AVAT21001Mfg Feb 2021 · Exp Jan 2023 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Jun 2022 |
| Atorvastatin Tablets I.P. 20 mg. | Batch AVAT21001Mfg Feb 2021 · Exp Jan 2023 | DissolutionDissolution | RDTL GuwahatiState lab | Aug 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.